Law firm Stephenson Harwood LLP has strengthened its life sciences and corporate capabilities with the arrival of James Gubbins, who joins the firm in London.
James is a corporate lawyer with deep expertise in the life sciences and technology sectors. He has extensive experience advising on mergers and acquisitions, venture capital financings, private equity transactions as well as IPOs and other securities issues. His clients include corporates, venture capital funds and investment banks.
“James is a highly respected senior lawyer with a deep understanding of the complex strategic, regulatory, and transactional issues and opportunities faced by the life sciences industry,” said Tom Nicholls, Global Head of Corporate at Stephenson Harwood. “His addition significantly broadens our bench depth in the life sciences and healthcare space, which is a key area for the firm.”
“Life sciences and healthcare is a strategic sector group for Stephenson Harwood, and James’s reputation and experience further elevates our profile in this space,” said Alexandra Pygall, Head of Life Sciences and Healthcare, Stephenson Harwood. “His arrival is testament to the quality of work we do and the service we deliver to our clients.”
“I am delighted to be joining Stephenson Harwood,” James Gubbins said. “The life sciences practice is well-regarded and I look forward to supporting the firm in growing this vital area.”
Stephenson Harwood’s international corporate practice acts for listed and private companies, financial institutions, private equity houses and management teams across a broad range of industries, including technology, life sciences, financial services and transportation. In the life sciences and healthcare sector, the group works with a wide range of clients including pharmaceutical, biotechnology, medical device, diagnostic and healthcare service companies, manufacturers, distributors and logistics companies, investors, banks and financial institutions.
